|
|||||
|
|
Treatment persistence in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists in clinical practice in Sweden |
|
| Authors: | Ann-Marie Svensson PhD Anders Toll PhD Jeremie Lebrec PhD Mervete Miftaraj MSc Stefan Franzén PhD Björn Eliasson MD |
| Affiliation: | 1. National Diabetes Register, Centre of Registers, Gothenburg, Sweden University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden;2. Eli Lilly Sweden AB, Solna, Sweden;3. HaaPACS GmbH, Schriesheim, Germany;4. National Diabetes Register, Centre of Registers, Gothenburg, Sweden;5. University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden |
| Abstract: | |
| Keywords: | antidiabetic drug GLP-1 analogue population study type 2 diabetes |